Thermo Fisher Scientific talks qPCR, digital PCR, NGS for infectious diseases at AMP 2022

Leo O'Connor
Nov 17, 2022
Latest in Business Insights
Handcuffs Gavel Social
Texas lab owner pleads guilty in $1.7M Medicare fraud
December 6, 2023
Doctor Lab Test Bipoc Social
Imaware acquires Binx Health’s consumer-testing business
December 6, 2023
Cancer Therapy Targeted Social
Guardant Health, Cancer Research UK partner on data and research
December 5, 2023
Lawsuit Social
Court issues injunction against Invitae, ArcherDx in Natera patent infringement suit
December 4, 2023
Related Stories
Hands Shaking Deal
Mergers & Acquisitions
Thermo Fisher Scientific, Heska complete previously announced acquisitions
3 D Monkeypox Infecting Cell Social
PCR
Thermo Fisher Scientific obtains FDA EUA for monkeypox/orthopox virus DNA kit
Sequencing Dna Rna Social
Cancer
AMP assesses clinical implementation of past standards, guidelines for sequence variants in cancer
Picture1
Trends and Finance
PCR-based life science tools top $5B, with digital PCR showing rapid growth: SDi report
More in Business Insights
Texas lab owner pleads guilty in $1.7M Medicare fraud
A Plano, TX, lab owner has pleaded guilty to orchestrating a scheme to obtain $1.7 million from Medicare fraudulently, announced the office of the U.S. Attorney for the Northern District of Texas in a statement.
December 6, 2023
Handcuffs Gavel Social
Imaware acquires Binx Health’s consumer-testing business
Molecular diagnostics and consumer testing company Imaware has acquired Binx Health’s at-home consumer testing business for an undisclosed sum.
December 6, 2023
Doctor Lab Test Bipoc Social
Guardant Health, Cancer Research UK partner on data and research
London-based Cancer Research UK and its innovation unit, Cancer Research Horizons, are collaborating with Guardant Health on sharing technology, data, and research insights for advancing cancer detection and treatment.
December 5, 2023
Cancer Therapy Targeted Social
Court issues injunction against Invitae, ArcherDx in Natera patent infringement suit
The U.S. District Court for the District of Delaware has issued a permanent injunction against Invitae and its subsidiary ArcherDx, ordering them to stop using products containing material patented by Natera.
December 4, 2023
Lawsuit Social
Personalis to cut workforce, forms new collaboration with Tempus
In a strategy intended to cut costs, cancer genomics company Personalis has approved a layoff of up to 65 employees, approximately 20% of the Fremont, CA-based company’s workforce.
December 4, 2023
Layoff Woman Belongings Social
FDA issues safety warning for risk of T-cell malignancies with CAR T-cell therapies
The FDA issued a safety warning that patients who have received treatment with BCMA- or CD19-directed autologous CAR T-cell immunotherapies may be at higher risk of developing new T-cell malignancies, including CAR-positive lymphoma.
November 30, 2023
T Cell Social
KSQ Therapeutics receives FDA clearance for trial of CRISPR-Cas9 engineered tumor therapy
Biotech firm KSQ Therapeutics has received clearance from the U.S. Food and Drug Administration (FDA) to proceed with a phase I and II trial of KSQ-001EX, KSQ’s CRISPR-Cas9 engineered tumor-infiltrating lymphocyte program.
November 29, 2023
Crispr Cas9 Gene Editing Social
Candel Therapeutics to lay off 50% of workforce, refocus on advanced oncology immunotherapies
Candel Therapeutics, a biopharmaceutical company focused on developing cancer-fighting immunotherapies, will lay off 50% of its workforce.
November 28, 2023
Business Graph Money Stocks Social
Scipher Medicine, Quest Diagnostics collaborate on RA diagnostics
Scipher Medicine and Quest Diagnostics have announced a multiyear collaboration to expand access to diagnostic services for patients with rheumatoid arthritis (RA).
November 28, 2023
Blood Test Samples Lab Social
Nasdaq issues delisting notice to T2 Biosystems
T2 Biosystems has received a delisting notice from Nasdaq after failing to satisfy the minimum $35 million market value of listed securities threshold required to remain listed.
November 27, 2023
Stock Exchange Social
AMP, other stakeholders urge Congress to pause FDA LDT rule, update CLIA
The Association for Molecular Pathology (AMP) requested Congress to update the Clinical Laboratory Improvement Amendments (CLIA) as an alternative to the FDA’s proposed rule to increase agency oversight of laboratory-developed tests (LDTs).
November 22, 2023
Washington Dc Capitol Social
U.K. regulators approve "world-first" sickle-cell gene therapy
U.K. medical regulators have approved a “world-first” gene therapy that aims to cure two blood disorders: sickle cell disease and transfusion-dependent β-thalassemia. They are the first regulatory body to approve the treatment.
November 20, 2023
Sickle Cell Anemia2 Social
Page 1 of 168
Next Page